Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will be featured in HighRes’ Lightning Talk at the NVIDIA GTC AI ...
Vitalik maps out quantum risks as Ethereum Strawmap outlines seven forks to strengthen post-quantum security, scalability, and finality.
Excessive social media use fragments attention, promotes shallow thinking, reinforces echo chambers, and weakens memory and ...
On January 29, Chinese developer Qu Jiangfeng was using Antigravity AI, a product of Google DeepMind, to clean up project ...
Sasha Stiles turned GPT-2 experiments into a self-writing poem at a Museum of Modern Art installation—and a new way to think about text-generating AI optimization ...
Wraithwatch, an AI cyber defense company founded by veterans of JSOC, Palantir, SpaceX, and Anduril, has been selected for a ...
VectorCertain's AIEOG Conformance Suite reveals that the Prevention Gap has a physical address: over 1.2 billion processors which process trillions of dollars daily with no on-device AI defense ...
Recursion Pharmaceuticals (RXRX) stock surged after the company significantly beat Street forecasts with its Q4 2025 results.
Guidance extended from year-end 2027 to early 2028, with operating expense reduction targets reiterated and achieved at a greater scale (now 35% year-over-year, 10% below guidance). Strategic focus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results